83
51
Growth Score 83 in past quarter
-4 pts
Heat Score 51 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3426360
Arestyr OncoLogic is a biotechnology company that develops both diagnostics and therapies for cancer.
About the Company
Arestyr OncoLogic is a biotechnology company that develops both diagnostics and therapies for cancer. Its proprietary technology is based on its unique understanding of a specific molecular structure found in late-stage cancer cells. Arestyr’s technology targets these cells by generating an immune response in the form of antibodies. The antibodies
then serve as a biomarker to show where the cancer cells are located.